Abametapir - Hatchtech
Alternative Names: BRN-0123183; DeOvo Lotion; DFD-11; HA-44; Ha44; Ha44 Gel; Xeglyze LotionLatest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Hatchtech
- Developer Dr Reddys Laboratories; Hatchtech
- Class Antiparasitics; Heterocyclic compounds; Pyridines; Small molecules
- Mechanism of Action Chelating agents; Metalloprotease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Pediculosis
Most Recent Events
- 27 Jul 2020 Registered for Pediculosis (In adolescents, In children, In infants, In adults) in USA (Topical)
- 18 Jun 2020 FDA assigns PDUFA action date of 12/08/2020 for Abametapir for Pediculosis (Dr Reddy's Laboratories website, June 2020)
- 31 Mar 2019 Abametapir is still in preregistration phase for Pediculosis in USA